|
Wang, Hongyun; Leav, Irwin; Ibaragi, Soichiro et al. (2008) SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res 68:1625-30
|
|
Wang, Hongyun; McKnight, Nicole C; Zhang, Tao et al. (2007) SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Cancer Res 67:528-36
|
|
Yuan, Xin; Li, Tong; Wang, Hongyun et al. (2006) Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells. Am J Pathol 169:682-96
|
|
Fu, Maofu; Rao, Mahadev; Wang, Chenguang et al. (2003) Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 23:8563-75
|
|
Masiello, David; Cheng, Shinta; Bubley, Glenn J et al. (2002) Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. J Biol Chem 277:26321-6
|
|
Cheng, Shinta; Brzostek, Sabrina; Lee, Suzanne R et al. (2002) Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. Mol Endocrinol 16:1492-501
|
|
Balk, Steven P (2002) Androgen receptor as a target in androgen-independent prostate cancer. Urology 60:132-8; discussion 138-9
|
|
Yuan, X; Lu, M L; Li, T et al. (2001) SRY interacts with and negatively regulates androgen receptor transcriptional activity. J Biol Chem 276:46647-54
|
|
Stanbrough, M; Leav, I; Kwan, P W et al. (2001) Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci U S A 98:10823-8
|
|
Taplin, M E; Bubley, G J; Ko, Y J et al. (1999) Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res 59:2511-5
|
Showing the most recent 10 out of 14 publications
